Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration clearance and launch of the BD ProbeTec™ Trichomonas vaginalis Qx Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and vaginal […]
Spartan Bioscience today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of the Spartan RX CYP2C19 System. It provides genetic results in less than 60 minutes from a non-invasive cheek swab. The automated system is indicated as an aid for clinicians to determine therapeutic strategy for drugs metabolized by […]
Franklin Lakes, NJ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, supports the U.S. Food and Drug Administration’s (FDA’s) proposed reclassification of rapid influenza detection tests. A hearing, held on June 13th by FDA’s CDRH Microbiology Devices Advisory Committee Meeting, examined the FDA’s proposal to reclassify rapid influenza detection […]
Emory Genetics Laboratory, through a partnership with Verinata Health, an Illumina company, will begin providing the verifi® prenatal test for patients desiring non-invasive prenatal testing. All pregnant women within the Emory Genetics Laboratory network determined to be high-risk by their physicians will be offered the option of the verifi prenatal test. The verifi prenatal test […]
BOSTON, MA – Partners HealthCare today announced that it has started offering doctors and patients the option of whole genome sequencing, analysis and interpretation. The test, available to patients across the nation, will offer physicians and patients the ability to better diagnose and treat disease. Partners is the one of the first health care systems […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the worldwide commercial availability of the Tina-quant HbA1cDx Gen.2 laboratory test, which aids healthcare professionals in diagnosing and monitoring diabetes in addition to identifying at-risk patients. Thanks to this new test, which will be commercially available in the third quarter of 2013 as part of the COBAS […]
Melbourne, Australia,: Agenix Limited (ASX: AGX) is pleased to announce that it has entered into a co-operation and cross-licensing agreement with Scotland based Arrayjet Limited, a specialist with existing expertise and intellectual property in microarray technology. The agreement commits the partners to undertake R & D both in Scotland and Australia to jointly develop a […]
Temecula, Calif. – Golden West Biologicals, Inc.® (GWB) a leading U.S.-based provider and manufacturer of diagnostic products, today announced the appointment of a new distributor for Korea. The company anticipates adding several more worldwide distributors in the coming months. “With more than 700 customers worldwide, we see a tremendous opportunity for growth of our Mass […]
SAN DIEGO — Epic Sciences, Inc. (“Epic”), a private biotech company that develops breakthrough cancer diagnostics, announced the appointment of Murali K. Prahalad, Ph.D. as president and CEO. Dr. Prahalad was formerly vice president of Corporate Strategy at Life Technologies, where he helped shape the organic and inorganic investment priorities across Life Technologies’ research tools, […]
RVINE, Calif., — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that in a letter dated August 20, 2013, from the Director of Listing Qualifications of The Nasdaq Stock Market LLC, the Company was informed that it has regained compliance with Listing Rule […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
